Medroxyprogesterone Acetate 150 mg/mL

Medroxyprogesterone Acetate 150 mg/mL is an extended-release injection used for contraception and hormone therapy. This medication is designed for intramuscular administration and is manufactured by Amphastar Pharmaceuticals, Inc.

Medroxyprogesterone Acetate 150 mg/mL is primarily used for contraception and hormone replacement therapy. It works by altering the menstrual cycle to prevent ovulation, making it a popular choice for long-term birth control. Additionally, it may be prescribed for managing certain hormonal conditions.

Common effects of Medroxyprogesterone Acetate 150 mg/mL may include changes in menstrual bleeding patterns, such as lighter or missed periods. Some users may experience headaches, weight changes, or mood swings. These effects can vary widely among individuals.

Medroxyprogesterone Acetate 150 mg/mL should be administered intramuscularly by a healthcare professional. It is important to discuss any pre-existing medical conditions, such as liver disease or a history of blood clots, with your healthcare provider before use. Regular monitoring may be required during treatment.

Medroxyprogesterone Acetate 150 mg/mL may interact with certain medications, including those metabolized by the liver's cytochrome P450 system. It is advisable to inform your healthcare provider about all medications you are taking, including over-the-counter drugs and supplements, to avoid potential interactions.